GEVO - Gevo, Inc.
NASDAQ
->
Basic Materials
->
Specialty Chemicals
Englewood,
United States
Type: Equity
GEVO price evolution
GEVO
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $315.32 | $340.56 | $375.6 | |
| Short term investments | ||||
| Net receivables | $2.3 | $2.28 | $2.49 | $2.62 |
| Inventory | $5.85 | $3.44 | $3.76 | $3.81 |
| Total current assets | $236.63 | $258.11 | $282.3 | $386.38 |
| Long term investments | ||||
| Property, plant & equipment | $223.19 | $236.85 | $229.18 | $213.1 |
| Goodwill & intangible assets | $5.94 | $6.23 | $6.52 | |
| Total noncurrent assets | $359.81 | $351.27 | $263.94 | |
| Total investments | ||||
| Total assets | $603.79 | $617.91 | $633.57 | $650.32 |
| Current liabilities | ||||
| Accounts payable | $1.61 | $23.3 | $21.56 | $22.75 |
| Deferred revenue | ||||
| Short long term debt | $1.95 | $0.51 | $68.67 | |
| Total current liabilities | $28.67 | $25.25 | $22.06 | $91.43 |
| Long term debt | $67.52 | $68.82 | $69.56 | $1.51 |
| Total noncurrent liabilities | $69.92 | $69.56 | $1.51 | |
| Total debt | $70.77 | $70.07 | $70.18 | |
| Total liabilities | $99.07 | $95.17 | $91.63 | $92.93 |
| Shareholders' equity | ||||
| Retained earnings | -$782.63 | -$761.47 | -$740.47 | -$721.6 |
| Other shareholder equity | ||||
| Total shareholder equity | $522.74 | $541.95 | $557.39 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $375.6 | $238.16 | $65.86 | $78.34 |
| Short term investments | $167.41 | $275.34 | ||
| Net receivables | $2.62 | $0.48 | $0.98 | $0.53 |
| Inventory | $3.81 | $6.35 | $2.75 | $2.26 |
| Total current assets | $386.38 | $415.42 | $351.79 | $83.27 |
| Long term investments | $77.22 | $134.56 | $1.5 | |
| Property, plant & equipment | $213.1 | $178.42 | $168.85 | $66.41 |
| Goodwill & intangible assets | $6.52 | $7.69 | $8.94 | |
| Total noncurrent assets | $263.94 | $285.33 | $314.69 | $68.83 |
| Total investments | $244.63 | $409.9 | $1.5 | |
| Total assets | $650.32 | $700.75 | $666.48 | $152.1 |
| Current liabilities | ||||
| Accounts payable | $22.75 | $5.01 | $28.29 | $4.12 |
| Deferred revenue | ||||
| Short long term debt | $68.67 | $0.68 | $4.34 | $0.81 |
| Total current liabilities | $91.43 | $25.44 | $32.63 | $4.93 |
| Long term debt | $1.51 | $67.56 | $86.5 | $0.46 |
| Total noncurrent liabilities | $1.51 | $69.83 | $86.59 | $0.79 |
| Total debt | $70.18 | $69.69 | $90.85 | $1.27 |
| Total liabilities | $92.93 | $95.27 | $119.22 | $5.72 |
| Shareholders' equity | ||||
| Retained earnings | -$721.6 | -$655.38 | -$557.38 | -$498.17 |
| Other shareholder equity | -$1.04 | -$0.61 | ||
| Total shareholder equity | $557.39 | $605.48 | $547.25 | $146.38 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.26 | $3.99 | $4.37 | |
| Cost of revenue | $3.42 | $2.59 | $3.15 | |
| Gross Profit | $1.84 | $1.4 | $1.22 | |
| Operating activities | ||||
| Research & development | $1.64 | $1.55 | $1.92 | |
| Selling, general & administrative | $11.51 | $12.15 | $10.74 | |
| Total operating expenses | $25.87 | $24.54 | $22.56 | |
| Operating income | -$24.03 | -$23.14 | -$21.34 | |
| Income from continuing operations | ||||
| EBIT | -$19.89 | -$18.33 | -$17.93 | |
| Income tax expense | ||||
| Interest expense | $1.11 | $0.54 | $0.55 | |
| Net income | ||||
| Net income | -$21 | -$18.88 | -$18.48 | |
| Income (for common shares) | -$21 | -$18.88 | -$18.48 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17.2 | $1.18 | $0.71 | $5.54 |
| Cost of revenue | $11.99 | $8.7 | $12.16 | $15 |
| Gross Profit | $5.21 | -$7.52 | -$11.45 | -$9.47 |
| Operating activities | ||||
| Research & development | $6.64 | $7.43 | $6.78 | $4.09 |
| Selling, general & administrative | $42.63 | $39.94 | $25.49 | $12.53 |
| Total operating expenses | $87.04 | $95.16 | $48.64 | $16.87 |
| Operating income | -$81.83 | -$102.69 | -$60.09 | -$26.34 |
| Income from continuing operations | ||||
| EBIT | -$64.05 | -$96.84 | -$58.95 | -$38.09 |
| Income tax expense | ||||
| Interest expense | $2.16 | $1.17 | $0.25 | $2.09 |
| Net income | ||||
| Net income | -$66.22 | -$98.01 | -$59.2 | -$40.19 |
| Income (for common shares) | -$66.22 | -$98.01 | -$59.2 | -$40.19 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$21 | -$18.88 | -$18.48 | |
| Operating activities | ||||
| Depreciation | $4.28 | $4.45 | $4.68 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.47 | $4.23 | $4.33 | |
| Total cash flows from operations | -$11.44 | -$16.08 | -$32.59 | |
| Investing activities | ||||
| Capital expenditures | -$9.2 | -$17.51 | $6.96 | |
| Investments | ||||
| Total cash flows from investing | -$37.19 | -$9.2 | -$17.51 | $6.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$2.67 | -$1.4 | ||
| Net borrowings | -$0.27 | -$0.06 | -$0.04 | |
| Total cash flows from financing | -$6.99 | -$4.6 | -$1.45 | -$0.04 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$82.73 | -$25.23 | -$35.04 | -$25.67 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$66.22 | -$98.01 | -$59.2 | -$40.19 |
| Operating activities | ||||
| Depreciation | $19.01 | $7.89 | $5.18 | $5.97 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17.09 | $17.42 | $9.87 | $2.13 |
| Total cash flows from operations | -$53.72 | -$52.61 | -$43.54 | -$19.34 |
| Investing activities | ||||
| Capital expenditures | -$54.42 | -$75.78 | -$68.83 | -$5.91 |
| Investments | $168.55 | $169.18 | -$342.79 | |
| Total cash flows from investing | $114.13 | $93.39 | -$411.62 | -$5.91 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $149.72 | $483.45 | $93.15 | |
| Net borrowings | -$0.19 | -$0.16 | $64.35 | $0.5 |
| Total cash flows from financing | -$0.19 | $138.56 | $512.85 | $87.28 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $60.22 | $179.34 | $57.7 | $62.04 |
News
Fundamentals
| Market cap | $591.34M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 239.41M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.17 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 8.25 |
| Quick ratio | 8.05 |